Welcome to Mendus’ Investor Relations page. Mendus is listed on NASDAQ Stockholm under the ticker symbol IMMU. You will find all relevant information on the Mendus share in our Investors section.
For an overview of all press releases in connection with the Negma financing agreement, please go to Convertible bonds.
Mendus secures second shareholder loan from Van Herk Investments and reduces the number of outstanding convertible bonds with Negma Group
Mendus AB today announced that the Company has closed a second loan under the terms of the commitment from its largest shareholder Van Herk Investments...
Mendus AB (publ) announces Q4 and year-end results 2022
“We are very happy with the progress we have made on all fronts in 2022 and the continued commitment of our entire team to develop impactful new cancer therapies. For 2023, we have taken necessary steps to focus on our most value-generating projects...